Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%) Zydus Lifesciences - Quaterly Results
Date: 07-11-2025
The September 2025 quarter revenue stood at Rs. 28712.00 millions, up 9.56% as compared to Rs. 26206.00 millions during the corresponding quarter last year.A good growth in profit of 46.44% reported to Rs. 11566.00 millions over Rs. 7898.00 millions of corresponding previous quarter.Operating profit for the quarter ended September 2025 rose to 16934.00 millions as compared to 12689.00 millions of corresponding quarter ended September 2024.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202509 | 202409 | % Var | 202509 | 202409 | % Var | 202503 | 202403 | % Var | |
| Sales | 28712.00 | 26206.00 | 9.56 | 54595.00 | 67808.00 | -19.49 | 151163.00 | 108187.00 | 39.72 |
| Other Income | 9373.00 | 3813.00 | 145.82 | 10944.00 | 4879.00 | 124.31 | 9058.00 | 11595.00 | -21.88 |
| PBIDT | 16934.00 | 12689.00 | 33.45 | 24359.00 | 37484.00 | -35.01 | 84325.00 | 51435.00 | 63.94 |
| Interest | 1138.00 | 959.00 | 18.67 | 2514.00 | 2113.00 | 18.98 | 4639.00 | 3907.00 | 18.74 |
| PBDT | 15796.00 | 11730.00 | 34.66 | 21845.00 | 35371.00 | -38.24 | 79686.00 | 47442.00 | 67.97 |
| Depreciation | 1360.00 | 1337.00 | 1.72 | 2660.00 | 2643.00 | 0.64 | 5239.00 | 5044.00 | 3.87 |
| PBT | 14436.00 | 10393.00 | 38.90 | 19185.00 | 32728.00 | -41.38 | 74447.00 | 42398.00 | 75.59 |
| TAX | 2870.00 | 2495.00 | 15.03 | 3772.00 | 7822.00 | -51.78 | 16698.00 | 7983.00 | 109.17 |
| Deferred Tax | 53.00 | 9.00 | 488.89 | 59.00 | 20.00 | 195.00 | 873.00 | -1360.00 | -164.19 |
| PAT | 11566.00 | 7898.00 | 46.44 | 15413.00 | 24906.00 | -38.12 | 57749.00 | 34415.00 | 67.80 |
| Equity | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 | 1006.00 | 1006.00 | 0.00 |
| PBIDTM(%) | 58.98 | 48.42 | 21.81 | 44.62 | 55.28 | -19.29 | 55.78 | 47.54 | 17.33 |